![](https://healthysavings.in/wp-content/uploads/2022/12/Hester-scaled.jpg)
Hester Biosciences to acquire technology from ICAR – NIHSAD to develop H9N2 avian influenza vaccine for poultry
Hester Biosciences announced the signing of an agreement with the Indian Council of Agricultural Research – National Institute of High Security Animal Diseases (ICAR-NIHSAD) to receive indigenously developed technology for the development and commercialization of the low pathogenic avian influenza (H9N2 strain) inactivated vaccine for poultry. The low pathogenic avian influenza H9N2 strain causes comorbidity